הרמונט
pfizer pfe pharmaceuticals israel ltd - ethinylestradiol; gestodene - טבליות מצופות - ethinylestradiol 0.020 mg; gestodene 0.075 mg - gestodene and estrogen - gestodene and estrogen - contraceptive.
מינס
pfizer pfe pharmaceuticals israel ltd - ethinylestradiol; gestodene - טבליות מצופות פילם - ethinylestradiol 0.015 mg; gestodene 0.06 mg - gestodene and estrogen - gestodene and estrogen - contraceptive.
אמילי
abic marketing ltd, israel - ethinylestradiol; gestodene - טבליות מצופות - gestodene 0.075 mg; ethinylestradiol 0.02 mg - gestodene and estrogen - gestodene and estrogen - oral contraception.
שלי
abic marketing ltd, israel - ethinylestradiol; gestodene - טבליות מצופות - ethinylestradiol 0.03 mg; gestodene 0.075 mg - gestodene and estrogen - gestodene and estrogen - oral contraception.
אוורה
trima israel pharmaceutical products maabarot ltd - ethinylestradiol; norelgestromin - מדבקות - norelgestromin 6 mg; ethinylestradiol 0.6 mg - norelgestromin and estrogen - norelgestromin and estrogen - female contraception. evra is intended for women of fertile age.
מינולט
pfizer pfe pharmaceuticals israel ltd - ethinylestradiol; gestodene - טבליה - gestodene 0.075 mg; ethinylestradiol 0.030 mg - ethinylestradiol - ethinylestradiol - contraception.
נוברינג
organon pharma israel ltd., israel - ethinylestradiol; etonogestrel - טבעת וגינלית - ethinylestradiol 2.7 mg; etonogestrel 11.7 mg - ethinylestradiol - ethinylestradiol - contraception. the safety and efficacy has been established in women aged 18 to 40 years.
פלורט
dexcel ltd, israel - ethinylestradiol; gestodene - טבליה - ethinylestradiol 0.03 mg; gestodene 0.075 mg - ethinylestradiol - ethinylestradiol - contraceptive.
פליים
dexcel ltd, israel - ethinylestradiol; gestodene - טבליה - ethinylestradiol 0.02 mg; gestodene 0.075 mg - ethinylestradiol - ethinylestradiol - contraceptive.
פרו-קיור 5 מג
merck sharp & dohme israel ltd - finasteride - טבליה - finasteride 5 mg - finasteride - finasteride - for the treatment and control of benign prostatic hyperplasia (bph) and for the prevention of urologic events to: reduce the risk of acute urinary retention. reduce the risk of surgery including transurethral resection of the prostate (turp)and prostatectomy. pro-cure causes regression of the enlarged prostate, improves urinary flow and improves the symptoms assocciated with bph. patients with an enlarged prostate are the appropriate candidates for therapy with pro-cure.